About MEMS   |   Council   |   Members Centre   |   Membership   |   Contact Us   |   Home
  Member Login     username:     password:           Forgot your password?
  Home » Announcements & Updates » 
President's Message
The Endocrine Directory
Calendar of Events
Announcements & Updates
Breaking News & Reports
In the Press
Disease Areas
Healthy Lifestyle
Research Programs
Photo & Video Gallery
Useful Links
Disease Management
arrow SPM 2017 - Diabetes Dikalangan Kanak – Kanak [27 Nov 2017]
Kadar Peningkatan Penghidap Diabetes Dikalangan Kanak-Kanak Semakin Meningkat Kanak-kanak ini memerlukan bantuan untuk memastikan kencing manis mereka dikawal dengan baik.
»

arrow Understanding Growth Disorders - BFM Interview with Assoc Prof Dr Muhammad Yazid Jalaludin, Consultant Paediatrician and Paediatric Endocrinologist
Physical growth is one of the most visible developmental milestones in a child’s development stage. But what happens if a child doesn’t seem to be achieving a normal height, weight or sexual maturity?
»

arrow Invitation to participate in the 4th APNETS Conference from the 13th to 15th October 2016
The Asia Pacific Neuroendocrine Tumour Society (APNETS) will be organizing the 4th APNETS Conference from the 13th to 15th October 2016 in G-Hotel, Penang, Malaysia.
»

arrow Invitation to participate in the Malaysian Osteoporosis Society 2016 Annual Scientific Meeting
MEMS will sponsor the registration for twenty (20) members to MOS ASM 2016 in August, on a first-come-first-serve basis. Kindly send in your name and details (title, name, profile, work address, email, mobile no) to latest by 31st July 2016 if you wish to participate in this meeting.
»

arrow MEMS wishing you Selamat Hari Raya Aidil Fitri 2016 - Maaf Zahir & Bathin
Salams to all MEMS members,
On behalf of the MEMS Executive Council, I would like to take this opportunity to wish all Muslim colleagues a blessed and peaceful Hari Raya Aidil Fitri. Let us celebrate this special occasion by expressing gratitude and forgiveness, practising humility and moderation in the spirit of togetherness.
»

arrow FDA strengthens kidney warnings for diabetes medicines canagliflozin (Invokana) and dapagliflozin (Forxiga) (Safety Announcement)
The U.S. Food and Drug Administration (FDA) has strengthened the existing warning about the risk of acute kidney injury for the type 2 diabetes medicines canagliflozin (Invokana) and dapagliflozin (Forxiga). Based on recent reports, FDA has revised the warnings in the drug labels to include information about acute kidney injury and added recommendations to minimize this risk.
»


| | | |
© Copyright Malaysian Endocrine & Metabolic Society (MEMS)   2009 - 2016    All rights reserved.
designed & maintained: mobition